DHEA is one of the most abundant hormones in the human body at its peak — and one of the most dramatically declining ones with age. Dehydroepiandrosterone (DHEA) and its sulfated form DHEA-S are produced primarily by the adrenal glands and serve as the raw material from which the body manufactures estrogen and testosterone in peripheral tissues. Between the ages of 25 and 75, DHEA-S levels fall by approximately 80 to 90 percent — a steeper age-related decline than any other hormone in the body. Understanding what that decline means clinically, what the evidence shows about supplementation, and who actually benefits is more nuanced than most DHEA marketing suggests.
This article covers what DHEA is and where it comes from, what it does in the body across multiple systems, what the clinical evidence shows about DHEA supplementation for aging, and who is most likely to benefit from evaluation and treatment. For context on how DHEA fits within the broader hormonal picture that changes with age, see our article on how to read your hormone lab results. According to the National Institutes of Health, DHEA-S is the most abundant circulating steroid in humans and its age-related decline is one of the most consistent hormonal changes across all populations studied.
Quick answer
DHEA is a prohormone produced by the adrenal glands that serves as the precursor for both testosterone and estrogen. It peaks in the mid-20s and declines approximately 2 percent per year thereafter. Low DHEA-S is associated with reduced immune function, accelerated aging markers, lower energy, reduced libido, and poorer body composition. Evidence for supplementation is strongest in women with adrenal insufficiency, older adults with documented low levels, and perimenopausal women using vaginal DHEA (prasterone) for genitourinary symptoms — the only FDA-approved DHEA indication. Self-supplementation without lab evaluation carries real risks and is not recommended.
What DHEA Is and Where It Comes From
DHEA is a steroid hormone belonging to the androgen family, produced primarily by the zona reticularis of the adrenal cortex, with smaller contributions from the gonads and brain. It circulates predominantly as DHEA-S (the sulfated form), which serves as a stable reservoir that can be converted back to DHEA and then to active sex hormones as needed in peripheral tissues.
The conversion pathway matters: DHEA is converted in target tissues — skin, fat, muscle, brain, bone, liver — to testosterone and estrogens through locally acting enzymes. This means DHEA functions as a “hormone currency” that the body cashes in different ways depending on tissue type and individual enzyme activity. A man’s tissues will convert DHEA more toward androgens; a woman’s tissues toward estrogens. The same supplemental dose will therefore produce different downstream hormone effects in different people — which is one reason DHEA supplementation without monitoring produces unpredictable results.
DHEA vs DHEA-S: what your lab reports
Most lab panels report DHEA-S rather than DHEA itself, because DHEA-S is more stable in the bloodstream and provides a better picture of adrenal DHEA production over time. DHEA itself fluctuates significantly throughout the day and is less reliable as a single measurement. Normal DHEA-S ranges vary substantially by age and sex. A result that falls in the normal range for a 70-year-old may represent a significant decline from what was normal for that individual at 35. Age-appropriate reference ranges — not absolute reference ranges — are essential for interpreting DHEA-S meaningfully in the context of aging.
The Age-Related Decline: How Much and How Fast
The decline of DHEA-S with age is remarkably consistent across populations and has been documented in epidemiologic studies worldwide. Peak levels typically occur between ages 20 and 30. After that, decline is approximately linear at 2 percent per year, with significant individual variation. By age 70, most adults have DHEA-S levels that are 75 to 90 percent below their youthful peak.
DHEA-S Reference Ranges by Age (Approximate)
Age range
Men (mcg/dL)
Women (mcg/dL)
20-29 (peak)
280-640
65-380
30-39
120-520
45-270
40-49
95-430
32-240
50-59
70-310
26-200
60-69
42-290
13-130
70+ (typical decline)
28-175
10-90
Ranges are approximate and vary between laboratories. Clinical interpretation requires individual baseline context, not just comparison to the population range for the current age.
What DHEA Does in the Body
DHEA’s functions are wide-ranging precisely because it acts as a precursor to multiple downstream hormones and has direct receptor-mediated effects of its own. The major functions relevant to aging are as follows.
Precursor to sex hormones
The most clinically important function of DHEA in the context of aging is its role as the primary precursor for sex hormone production in peripheral tissues — particularly postmenopausally in women, when ovarian estrogen production has ceased. After menopause, circulating estrogen and testosterone come almost entirely from DHEA conversion in peripheral tissues. DHEA-S levels therefore become the dominant determinant of available sex hormone substrate in older women. This connection directly links DHEA status to bone density, sexual function, skin quality, and the symptoms of sex hormone deficiency in postmenopausal women. For a full discussion of how this connects to women’s hormone optimization, see our article on estrogen, progesterone, and mood.
Immune function and inflammation
DHEA exerts direct immunomodulatory effects beyond its role as a sex hormone precursor. It enhances natural killer cell activity, supports T-cell function, and has anti-inflammatory effects including downregulation of pro-inflammatory cytokines such as IL-6 and TNF-alpha. In animal models, DHEA supplementation improves immune responses to vaccines and infections. Observational studies in humans consistently find that lower DHEA-S levels in older adults are associated with higher inflammatory markers and increased susceptibility to infection. This immune-DHEA connection is one reason that very low DHEA-S is considered a potential biomarker of accelerated biological aging.
Bone density
DHEA supports bone density through both its conversion to estrogen (which inhibits osteoclast-mediated bone resorption) and through direct androgenic effects on bone tissue. Observational studies consistently show that lower DHEA-S is associated with lower bone mineral density in both men and women. Clinical trial results on supplementation and bone outcomes are mixed but generally positive in women with very low DHEA-S levels, particularly when combined with calcium and vitamin D.
Body composition
DHEA appears to support lean mass and oppose visceral fat accumulation through its downstream androgenic effects and through direct effects on fat cell metabolism. Animal studies show dramatic effects; human studies are more modest. In clinical trials of oral DHEA supplementation in older adults, the most consistent body composition findings are reductions in trunk fat and modest improvements in muscle mass, particularly when combined with resistance training. See our article on GLP-1 medications and testosterone for context on how multiple hormonal systems interact with body composition.
Cognition and mood
DHEA and its metabolites have neurosteroid properties — they are produced in the brain and modulate GABA, NMDA, and sigma receptors. Low DHEA-S has been associated with depression, reduced cognitive performance, and poor stress resilience in observational studies. Clinical trial results on cognition and mood have been mixed, with more consistent findings in populations with adrenal insufficiency or very low baseline DHEA-S levels than in the general population.
DHEA Functions Relevant to Aging: Evidence Summary
Sex hormone precursor
Primary substrate for estrogen and testosterone in peripheral tissues, especially critical postmenopausally.
Supports bone via estrogen conversion and direct androgenic effects. Clinical trial results mixed.
Evidence: Moderate
Body composition
Reduces visceral fat, supports lean mass in older adults. Effects modest without resistance training.
Evidence: Moderate
Mood and cognition
Neurosteroid effects on GABA, NMDA receptors. Consistent associations with depression; trial results mixed.
Evidence: Mixed
Cardiovascular
Lower DHEA-S associated with cardiovascular events in observational studies. Causal direction unclear from trials.
Evidence: Observational only
FDA-Approved DHEA: Prasterone for Genitourinary Symptoms
The only FDA-approved pharmaceutical DHEA product is prasterone (brand name Intrarosa), a vaginal insert approved in 2016 for the treatment of moderate to severe dyspareunia (painful intercourse) due to vulvovaginal atrophy associated with menopause. This is a critically important distinction: prasterone is approved as a prescription drug at a specific dose for a specific indication — it is not the same as the over-the-counter DHEA supplements sold at pharmacies.
Vaginal DHEA works through local conversion to estrogen and testosterone in vaginal tissue, restoring vaginal epithelium thickness, lubrication, and tissue integrity without significant systemic absorption — making it appropriate for women who cannot or do not want to use systemic estrogen. Clinical trials demonstrated significant improvements in vaginal dryness, painful intercourse, and sexual function compared to placebo. For women with genitourinary syndrome of menopause (GSM) who are not candidates for systemic hormone therapy, vaginal DHEA is an evidence-based first-line option. For a full comparison of women’s hormone therapy options, see our article on HRT vs bioidentical hormones.
Clinical note: OTC DHEA vs prescription prasterone
Over-the-counter DHEA supplements (25 mg, 50 mg, 100 mg tablets) are classified as dietary supplements in the US, not drugs. This means they are not subject to the same manufacturing standards, purity testing, or clinical evidence requirements as pharmaceuticals. Studies have found that the actual DHEA content in OTC supplements varies significantly from labeled amounts. Prescription prasterone is manufactured to pharmaceutical standards at a clinically validated dose for a specific indication. The fact that something contains DHEA does not make it equivalent to a clinically validated pharmaceutical product at the right dose for your specific situation.
DHEA Supplementation: What the Evidence Actually Shows
The clinical trial evidence for systemic DHEA supplementation in aging is more modest than the observational data would suggest, and the populations most likely to benefit are more specific than general marketing implies.
Adrenal insufficiency: clearest benefit
The evidence for DHEA supplementation is most consistent and clinically meaningful in patients with primary or secondary adrenal insufficiency (Addison’s disease, hypopituitarism), where DHEA production is directly impaired and supplementation restores a genuinely deficient hormone. Multiple randomized controlled trials in this population show improvements in wellbeing, mood, fatigue, and sexual function with DHEA replacement at physiological doses (typically 25 to 50 mg daily). These patients have documented deficiency, not just age-related decline — the distinction matters clinically.
Aging adults with low DHEA-S: more nuanced
For healthy older adults with age-related DHEA-S decline, the clinical trial evidence is mixed. The largest and most rigorous trials — including the DHEAge study — showed improvements in bone density, skin quality, and libido in older women with low DHEA-S, while results in men were less consistent. A meta-analysis published in 2023 found modest benefits for body composition and sexual function in women over 60 with low DHEA-S, with effects roughly equivalent to what would be expected from the testosterone produced by DHEA conversion. For more on how testosterone deficiency presents in women, see our article on the sexual health services we offer.
What typically does not respond to DHEA supplementation alone
Cognitive function, cardiovascular outcomes, longevity, and muscle strength in the absence of resistance training do not consistently improve in clinical trials of DHEA supplementation in healthy aging adults. The observational associations between low DHEA-S and poor outcomes in these areas appear to reflect DHEA-S as a biomarker of overall biological aging rather than a causal factor that supplementation can modify independently.
Risks of unsupervised DHEA supplementation
Because DHEA converts to both estrogen and testosterone, supplementation at common OTC doses (50 to 100 mg) in women can produce elevated estrogen or androgen levels that cause acne, hair loss, oily skin, mood changes, or hormonal disruption. In men, DHEA can convert to estrogen, potentially worsening estrogen-related symptoms. Women with hormone-sensitive cancers should not supplement DHEA without oncology consultation. DHEA at high doses may suppress the body’s own adrenal DHEA production through negative feedback. None of these risks are visible without laboratory monitoring before and during supplementation.
Who Should Consider DHEA Evaluation
DHEA-S should be part of a comprehensive hormonal evaluation in specific clinical contexts rather than being supplemented based on age alone. The following are the clearest indications for evaluation.
Known or suspected adrenal insufficiency. Anyone with confirmed Addison’s disease or hypopituitarism should have DHEA-S evaluated alongside cortisol and other adrenal hormones.
Women with genitourinary symptoms of menopause who are not candidates for or do not prefer systemic estrogen. Vaginal DHEA (prasterone) is an evidence-based option for this indication specifically.
Postmenopausal women with low libido, fatigue, and poor body composition whose estrogen and progesterone are already optimized but who still have residual symptoms. DHEA-S evaluation may identify a contributing androgen precursor deficiency.
Adults over 50 with comprehensive hormonal evaluations where DHEA-S provides context for the overall adrenal and sex hormone picture, particularly in patients with fatigue, immune vulnerability, or multiple aging-related symptoms.
Patients with chronic stress, sleep deprivation, or long-term corticosteroid use — all of which suppress adrenal DHEA production and may accelerate DHEA-S decline beyond age-expected levels.
DHEA-S is most useful when interpreted alongside the rest of the hormonal picture — testosterone, estradiol, cortisol, SHBG, and thyroid. It does not provide clinically actionable information in isolation. For the complete panel that includes DHEA-S alongside all other relevant markers, see our article on how to read your hormone lab results.
Tip: DHEA-S and cortisol tell different stories
Cortisol and DHEA-S are both produced by the adrenal glands, but they have an important inverse relationship in the context of stress. Chronic stress elevates cortisol while simultaneously suppressing DHEA-S production through competition for adrenal precursors (the pregnenolone pathway). A patient with chronically elevated cortisol and very low DHEA-S presents with a cortisol-to-DHEA-S ratio that some researchers use as a biomarker of chronic stress burden and biological aging. Addressing the elevated cortisol is the primary intervention in this pattern — not simply supplementing DHEA-S without understanding why it is low. For more on how sleep disruption drives cortisol elevation and hormonal decline, see our article on sleep and hormones.
Frequently Asked Questions
Should I take DHEA supplements if I am over 50?
Not without lab evaluation first. DHEA-S should be measured before supplementation to establish whether you actually have levels below what is appropriate for your age and sex. Supplementing based on age alone without knowing your baseline level can produce supraphysiological DHEA-S, which in turn produces elevated estrogen or testosterone that may be clinically problematic. If your DHEA-S is in the upper half of the age-appropriate range, supplementation adds no benefit and carries unnecessary risk.
What dose of DHEA is appropriate?
Physiological replacement doses in clinical research are typically 25 to 50 mg daily for most adults, with women generally requiring lower doses than men because they start from a lower baseline and are more sensitive to androgen conversion. OTC supplements commonly sold at 100 mg are above physiological replacement levels for most adults and more likely to produce side effects. The appropriate dose is the one that restores your DHEA-S to the optimal range for your age and sex — which requires lab monitoring, not a standard dose from a label.
Is DHEA a steroid? Is it banned in sports?
Yes and yes. DHEA is a steroid hormone — it is a precursor to anabolic steroids including testosterone. The World Anti-Doping Agency (WADA) prohibits DHEA use in competitive sports because of its testosterone-producing potential. Athletes subject to WADA testing should not use DHEA supplements. In clinical medicine, DHEA prescribed for documented deficiency is legal and appropriate. The supplement status of DHEA in the US (available OTC without prescription) is unusual internationally — in many countries DHEA is a controlled or prescription substance.
Can DHEA supplementation cause cancer?
The evidence does not support a causal link between DHEA supplementation at physiological doses and cancer initiation in people without pre-existing cancer. However, because DHEA converts to estrogen, it is contraindicated or requires oncology consultation in women with a history of estrogen receptor-positive breast cancer. Because it converts to testosterone, it may be inappropriate in men with active prostate cancer. Women with known or suspected hormone-sensitive cancers should discuss DHEA with their oncologist before any supplementation. For the general population without these risk factors, clinical trial data at physiological doses has not shown increased cancer rates.
Does DHEA improve energy and libido?
In people with documented low DHEA-S — particularly women with adrenal insufficiency and older postmenopausal women — clinical trials show meaningful improvements in energy and sexual function with DHEA restoration. In healthy individuals with DHEA-S in the normal range for their age, the evidence for energy and libido improvements is weak to absent. The effect is most pronounced when DHEA-S is genuinely below what is optimal for the individual’s age and sex, and when the downstream hormones (testosterone in particular) are also low — which is the specific situation where DHEA’s role as a precursor is most clinically relevant.
What is the difference between DHEA and 7-Keto DHEA?
7-Keto DHEA is a metabolite of DHEA that does not convert back to testosterone or estrogen — it cannot be aromatized. It is marketed specifically to people who want the proposed metabolic and immune benefits of DHEA without the risk of sex hormone elevation. The evidence base for 7-Keto DHEA is much more limited than for DHEA itself. Some studies suggest modest effects on metabolism and weight loss, but the data quality is insufficient for confident clinical recommendations. Because it does not raise testosterone or estrogen, it may be considered by women with hormone-sensitive conditions, but it also lacks the sex hormone precursor benefits that are the most well-documented effects of DHEA in aging women.
How long does it take for DHEA supplementation to show effects?
DHEA-S levels rise within the first few weeks of supplementation. Effects on subjective wellbeing, energy, and mood, when they occur, are typically noticed within 4 to 8 weeks. Body composition effects (reduced trunk fat, improved muscle mass) require at least 3 to 6 months of supplementation and are most pronounced when combined with resistance training. Sexual function improvements in postmenopausal women with low DHEA-S are typically reported within 8 to 12 weeks. Labs should be rechecked at 6 to 8 weeks after starting supplementation to confirm DHEA-S is in the target range and that downstream estrogen and testosterone have not elevated to clinically concerning levels.
Want to know if DHEA is relevant to your hormone picture?
Our specialists include DHEA-S as part of a comprehensive hormonal evaluation alongside testosterone, estradiol, cortisol, and thyroid. We interpret it in the context of your complete panel and symptom picture — not as an isolated number — and recommend intervention only when the evidence supports it for your specific situation.
This article is for informational and educational purposes only. It does not constitute medical advice, a diagnosis, or a treatment recommendation. DHEA supplementation requires individual laboratory evaluation and clinical assessment by a licensed healthcare provider. Women with hormone-sensitive cancers or cardiovascular risk factors should consult their oncologist or cardiologist before considering any DHEA supplementation. DHEA is prohibited by WADA in competitive sports. FDA approval of prasterone (Intrarosa) is for vaginal use only for the specific indication of dyspareunia due to menopause — it is not an approval of systemic DHEA supplementation for aging. If you are experiencing symptoms associated with hormonal decline, consult a licensed provider for appropriate evaluation and testing.
